Back to search

Article

Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific Biomarkers

2024-05-22

Abstract excerpt

<title>Abstract</title><p>Breast cancer is diagnosed in 2.3 million women each year, and kills 685,000 (~30% of patients) worldwide. Breast cancer prognosis for many subtypes has improved due to treatments targeting Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal growth factor Receptor 2 (HER2). In contrast, patients with triple-negative breast cancer (TNBC) tumors, which lack all three com...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3587d070-a617-541e-a0f8-daf043120469
DOI
10.21203/rs.3.rs-4415531/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersDOI 10.21203/rs.3.rs-4415531/v1
Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesSemantic proximity
A Retrospective View on Triple Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components using public Single-cell RNA Seq DatasetsSemantic proximity
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity
Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypesSemantic proximity
New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity
Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional ValidationSemantic proximity
Discovering triple negative breast cancers (TNBC) transcriptomic profiles via massive screening of single cell RNA-sequencing (scRNA-seq) datasetsSemantic proximity
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity
The Molecular Landscape and Utility of Multiomic Analyses in Triple Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic TargetsSemantic proximity
Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast CancerSemantic proximity
Molecular subtypes and precision treatment of triple-negative breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.